Oxford University to Resume Coronavirus Vaccine Trial after Pause

The third phase trial of a possible coronavirus vaccine, developed by Oxford University and AstraZeneca, will resume after a pause.

The UK pharmaceutical company AstraZeneca on Saturday issuing a press release confirmed about the trial, according to a BBC report.

The trial announcement came after UK’s Medicines Health Regulatory Authority approved the vaccine as “safe” after a review.

On Tuesday, AstraZeneca postponed its trial after a UK national who took the coronavirus vaccine in a trial fell ill.

Health Secretary Matt Hancock welcomed the news that the trials would resume, BBC reports.

He added, “This pause shows we will always put safety first. We will back our scientists to deliver an effective vaccine as soon as safely possible.”

US, UK, Brazil and South Africa allowed to conduct the final trial of Oxford University vaccine on their 30,000 people. Meanwhile, AstraZeneca postponed its trial on last Tuesday.

The AstraZeneca vaccines are also at the top of the global rankings in competition for Covid-19 vaccines.

 

Subscribe to Our Latest Newsletter

To Read Our Exclusive Content, Sign up Now.
$5/Monthly, $50/Yearly

RECENT POSTS

Scientists Create New Map of Zealandia, the World’s Largest Submerged Continent

A Russian ship full with sailors and, bizarrely, penguins...

15 Critical Factors that Triggers Proctalgia Fugax [Treatment Options]

Are you dealing with sharp and sudden pain in...

iPhone 15 Pro Max Durability Test: Loses to Samsung Galaxy S23 Ultra

Just when we thought we had seen it all...

NBA YoungBoy Net Worth With Biography in 2023 [Latest Updates]

NBA YoungBoy's meteoric rise in the music industry has...

Discord Login Issues: Discord Outage Affects Millions of Users Worldwide

Discord servers are now down, and users are having...

ASTROLOGY

LIFESTYLE

BUSINESS

TECHNOLOGY

HEALTH

FEATURED STORIES